Episode 185: John Maraganore on his next act, plus Moderna's setback & the drug pricing reform saga

STAT's Rachel Cohrs drops in to talk about the latest updates in drug pricing reform. Then, John Maraganore joins us to talk about his decision to step down as CEO of Alnylam Pharmaceuticals after almost 20 years with the company. We also discuss the latest news in biotech, including the Covid-19 vaccine for kids and Moderna's disappointing earnings call.

Episode metadata supplied by the publisher feed · Published Nov 4, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 185: John Maraganore on his next act, plus Moderna's setback & the drug pricing reform saga

0:00 28:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 28 minutes long.

When was this The Readout Loud episode published?

This episode was published on November 4, 2021.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!